KINGDON CAPITAL MANAGEMENT, L.L.C. - 30 Sep 2025 SCHEDULE 13G/A Report for Jasper Therapeutics, Inc. Voting Common Stock, par value $0.0001 per share (JSPR)

Filing Manager
KINGDON CAPITAL MANAGEMENT, L.L.C.
Reporting Manager
Kingdon Capital Management, L.L.C.
Security
Jasper Therapeutics, Inc. Voting Common Stock, par value $0.0001 per share
Symbol
JSPR
Shares outstanding
28,188,191 shares
Disclosed Ownership
1,324,845 shares
Ownership
4.7%
Form type
SCHEDULE 13G/A
Filing time
12 Nov 2025, 13:04:58 UTC
Date of event
30 Sep 2025
Previous filing
11 Jul 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"KINGDON CAPITAL MANAGEMENT, L.L.C. disclosed 4.7% ownership in Jasper Therapeutics, Inc. Voting Common Stock, par value $0.0001 per share (JSPR) on 30 Sep 2025."

Quick Takeaways

  • KINGDON CAPITAL MANAGEMENT, L.L.C. filed SCHEDULE 13G/A for Jasper Therapeutics, Inc. Voting Common Stock, par value $0.0001 per share (JSPR).
  • Disclosed ownership: 4.7%.
  • Date of event: 30 Sep 2025.

What Changed

  • Previous schedule filing date: 11 Jul 2025.
  • Current filing was accepted on 12 Nov 2025, 13:04.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Kingdon Capital Management, L.L.C. 4.7% 1,324,845 0 1,324,845 By: /s/ Richard Weinstein Richard Weinstein / Chief Operating Officer & General Counsel
Mark Kingdon 4.7% 1,324,845 0 1,324,845 By: /s/ Mark Kingdon Mark Kingdon

Sponsored